首页> 外文OA文献 >Development of a Poliovirus Neutralization Test with Poliovirus Pseudovirus for Measurement of Neutralizing Antibody Titer in Human Serum ▿
【2h】

Development of a Poliovirus Neutralization Test with Poliovirus Pseudovirus for Measurement of Neutralizing Antibody Titer in Human Serum ▿

机译:脊髓灰质炎病毒伪病毒对脊髓灰质炎病毒的中和试验的开发,用于测定人血清中的中和抗体滴度 ▿

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In the Global Polio Eradication Initiative, laboratory diagnosis plays a critical role by isolating and identifying poliovirus (PV) from the stool samples from acute flaccid paralysis (AFP) cases. In recent years, reestablishment of PV circulation in countries where PV was previously eliminated has occurred because of decreased herd immunity, possibly due to poor vaccination coverage. To monitor the vulnerability of countries to PV circulation, surveillance of neutralizing-antibody titers against PV in susceptible populations is essential in the end game of the polio eradication program. In this study, we have developed a PV neutralization test with type 1, 2, and 3 PV pseudoviruses to determine the neutralizing-antibody titer against PV in human serum samples. With this test, the neutralizing-antibody titer against PV could be determined within 2 days by automated interpretation of luciferase signals without using infectious PV strains. We validated the pseudovirus PV neutralization test with 131 human serum samples collected from a wide range of age groups (ages 1 to >60 years) by comparison with a conventional neutralization test. We found good correlation in the neutralizing-antibody titers determined by these tests. These results suggest that a pseudovirus PV neutralization test would serve as a safe and simple procedure for the measurement of the neutralizing-antibody titer against PV.
机译:在全球根除脊髓灰质炎行动中,实验室诊断通过从急性弛缓性麻痹(AFP)病例的粪便样本中分离和鉴定脊髓灰质炎病毒(PV)发挥关键作用。近年来,由于牛群免疫力下降(可能是由于疫苗接种覆盖率较差),在先前已取消PV的国家中恢复了PV循环。为了监测各国对PV循环的脆弱性,在消灭脊髓灰质炎计划的最后阶段,监测易感人群中针对PV的中和抗体滴度至关重要。在这项研究中,我们开发了用1型,2型和3型PV假病毒进行的PV中和测试,以确定人血清样品中针对PV的中和抗体效价。通过该测试,可以在2天内通过自动解释萤光素酶信号而不使用感染性PV菌株来确定针对PV的中和抗体滴度。通过与常规中和测试进行比较,我们使用了131种人血清样本对伪病毒PV中和测试进行了验证,这些样本来自各个年龄段(1至> 60岁)。我们发现这些测试确定的中和抗体滴度具有良好的相关性。这些结果表明,伪病毒PV中和试验将作为一种安全,简单的方法来测量针对PV的中和抗体效价。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号